TY - JOUR
T1 - Awareness, Willingness, and Use of Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Washington, DC and Miami-Dade County, FL
T2 - National HIV Behavioral Surveillance, 2011 and 2014
AU - Patrick, Rudy
AU - Forrest, David
AU - Cardenas, Gabriel
AU - Opoku, Jenevieve
AU - Magnus, Manya
AU - Phillips, Gregory
AU - Greenberg, Alan
AU - Metsch, Lisa
AU - Kharfen, Michael
AU - LaLota, Marlene
AU - Kuo, Irene
N1 - Funding Information:
This study was funded through cooperative agreements from the Centers for Disease Control and Prevention and through contracts from the Florida Department of Health and from the District of Columbia Department of Health.
Publisher Copyright:
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2017/7/1
Y1 - 2017/7/1
N2 - Introduction: Despite the effectiveness of oral pre-exposure prophylaxis (PrEP) for HIV prevention, knowledge, and uptake of this new prevention intervention over time has not been fully studied. Using NHBS data from 2 urban areas highly impacted by HIV, we examined awareness, use, and willingness to use daily oral PrEP and factors associated with willingness to take oral PrEP among men who have sex with men (MSM) over time. Methods: MSM from Washington, DC and Miami, FL were recruited in 2011 and 2014 using venue-based sampling. Participants completed behavioral surveys and HIV testing. Awareness, use, and willingness to use oral PrEP were examined. Demographic and behavioral correlates of being “very likely” to use PrEP in 2011 and 2014 were assessed. Results: PrEP awareness increased from 2011 to 2014 in both cities (DC: 39.1%-73.8% and Miami: 19.4%-41.2%), but use remained low in 2014 (DC: 7.7%; Miami: 1.4%). Being very likely to use PrEP decreased over time in DC (61%-48%), but increased in Miami (48%-60%). In DC, minority race was associated with increased odds of being very likely to use PrEP, whereas reduced odds of being very likely to use PrEP was observed for MSM with 1 or 2-5 partners versus having 6+ partners. In Miami, a higher proportion of white versus Hispanic MSM reported being very likely to use PrEP in 2011, but this observation was reversed in 2014. Conclusion: Geographic differences in awareness, use, and willingness to use PrEP indicate that innovative strategies are needed to educate MSM about this effective prevention strategy.
AB - Introduction: Despite the effectiveness of oral pre-exposure prophylaxis (PrEP) for HIV prevention, knowledge, and uptake of this new prevention intervention over time has not been fully studied. Using NHBS data from 2 urban areas highly impacted by HIV, we examined awareness, use, and willingness to use daily oral PrEP and factors associated with willingness to take oral PrEP among men who have sex with men (MSM) over time. Methods: MSM from Washington, DC and Miami, FL were recruited in 2011 and 2014 using venue-based sampling. Participants completed behavioral surveys and HIV testing. Awareness, use, and willingness to use oral PrEP were examined. Demographic and behavioral correlates of being “very likely” to use PrEP in 2011 and 2014 were assessed. Results: PrEP awareness increased from 2011 to 2014 in both cities (DC: 39.1%-73.8% and Miami: 19.4%-41.2%), but use remained low in 2014 (DC: 7.7%; Miami: 1.4%). Being very likely to use PrEP decreased over time in DC (61%-48%), but increased in Miami (48%-60%). In DC, minority race was associated with increased odds of being very likely to use PrEP, whereas reduced odds of being very likely to use PrEP was observed for MSM with 1 or 2-5 partners versus having 6+ partners. In Miami, a higher proportion of white versus Hispanic MSM reported being very likely to use PrEP in 2011, but this observation was reversed in 2014. Conclusion: Geographic differences in awareness, use, and willingness to use PrEP indicate that innovative strategies are needed to educate MSM about this effective prevention strategy.
KW - Men who have sex with men
KW - National HIV behavioral surveillance
KW - Pre-exposure prophylaxis
KW - Willingness to use PrEP
UR - http://www.scopus.com/inward/record.url?scp=85030999174&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030999174&partnerID=8YFLogxK
U2 - 10.1097/QAI.0000000000001414
DO - 10.1097/QAI.0000000000001414
M3 - Article
C2 - 28604442
AN - SCOPUS:85030999174
VL - 75
SP - S375-S382
JO - Journal of Acquired Immune Deficiency Syndromes
JF - Journal of Acquired Immune Deficiency Syndromes
SN - 1525-4135
ER -